Skip to main content

Year: 2026

TX Rail Products, Announces Fiscal 2026 Second Quarter Results

Revenue of $3.5 Million, an increase of 60% over prior year period Net Income of $391,000 Year-to-date Operating Cash Flow Rises to $1.6 Million, Reflecting Strong Improvement and Supporting Continued Growth ASHLAND, Ky., April 30, 2026 (GLOBE NEWSWIRE) — TX Rail Products, Inc. (OTC Markets PINK: TXRP), a supplier of rail and rail products to the U.S. coal mining industry, short line railroads and tunneling contractors, today announced financial results for the second fiscal quarter of 2026. CEO Comments Mr. Shrewsbury, CEO and Chairman of TX Rail Products, Inc., commented, “During the quarter, we continued to build on the momentum established over the past year, delivering strong top-line growth while maintaining consistent profitability. Demand across our core markets remained solid, and our team executed well in a dynamic operating...

Continue reading

Calian to Hold Conference Call Following Announcement of Second Quarter FY 2026 Results

OTTAWA, Ontario, April 30, 2026 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX:CGY), a mission-critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, will hold a conference call at 8:30 a.m. Eastern Time on Thursday, May 14, 2026, to discuss results for the three-month period ended March 31, 2026. The results will be released before markets open. Interested participants from the financial and media community should join the live presentation by going to the Calian website and clicking on the Investors section to find the conference call link or directly via the following URL: https://edge.media-server.com/mmc/p/apsntrjn A replay of the audio webcast will be available at the same location a few hours after the conclusion of the call. About Calian For over 40 years, Calian...

Continue reading

Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations

Some of Kraig Labs recently Reeled recombinant Spider SilkSome of Kraig Labs recently Reeled recombinant Spider SilkDENVER, April 30, 2026 (GLOBE NEWSWIRE) — (www.247marketnews.com)- Kraig Biocraft Laboratories (OTCQB: KBLB) (“Kraig Labs” or the “Company”), a leading developer of recombinant spider silk-based fibers, has achieved two major commercialization milestones, signaling accelerating momentum toward the first successful spider silk commercialization program. The Company announced that a recent production run yielded approximately 1.8 metric tons of recombinant spider silk, marking a significant increase in output and establishing a new benchmark for commercial-scale production. Equally important, Kraig Labs confirmed that the processing and reeling of this production batch proceeded successfully and according to...

Continue reading

Cartier Begins Trading on the OTCQB Venture Market in the U.S. Under Symbol ECRFF

VAL-D’OR, Quebec, April 30, 2026 (GLOBE NEWSWIRE) — Cartier Resources Inc. (“Cartier” or the “Company”) (TSXV: ECR; FSE: 6CA, OTCQB: ECRFF) is pleased to announce that its common shares are now trading on the OTCQB Venture Market, a U.S. market operated by OTC Markets Group Inc. (“OTC”) in New York, under the symbol ECRFF. Cartier will continue to trade on the TSX Venture Exchange under the symbol ECR. Philippe Cloutier, President and CEO of Cartier Resources, commented: “Cartier’s OTCQB listing marks an important step in the Company’s growth strategy and is expected to strengthen our visibility among American investors, improve trading liquidity and broaden access to the U.S. capital markets. We believe it will support increased investor engagement as we continue to advance our projects and long-term growth objectives.” The...

Continue reading

Banco Itaú Chile Announces First Quarter 2026 Management Commentary

SANTIAGO, Chile, April 30, 2026 (GLOBE NEWSWIRE) — BANCO ITAÚ CHILE (SSE: ITAUCL) announced today its Management Commentary for the first quarter ended March 31, 2026. For the full report, please refer to the webpage: https://ir.itau.cl/results-and-reports/quarterly-reports/ On Thursday, May 7, 2026, at 11:30 A.M. Santiago time (11:30 A.M. ET), the Company’s management team will host a conference call to discuss the financial results. The call will be hosted by André Gailey, CEO; Emiliano Muratore, CFO; and Andrés Perez, Chief Economist. Webinar Details: Online registration:  https://mzgroup.zoom.us/webinar/register/WN_DZSvSA6YTceMgzhVASKuxg#/registration All participants must pre-register using this link to join the webinar. Upon registering, each participant will be provided with details to connect to the call. Q&A session: The...

Continue reading

Aduro Clean Technologies to Participate in Industry and Investor Conferences in May 2026

LONDON, Ontario, April 30, 2026 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced its participation in several industry and investor conferences in May 2026. Conference and Trade Program Highlights:Investor presentation at D. Boral Capital Global Conference, covering Next Generation Process (NGP) Pilot Plant operating campaigns, FOAK industrial facility development at Chemelot, and recent commercial milestones. Investor presentation and meetings at LD Micro Invitational XVI, supporting ongoing capital markets engagement. Industry engagement at Plastics Recycling Show...

Continue reading

Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months

Ramat Gan, Israel, April 30, 2026 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment of cancer and inflammatory diseases, today announced  positive clinical data from its Phase 2a study of namodenoson in patients with advanced pancreatic cancer. The data from the fully enrolled study demonstrate preliminary evidence of clinical activity, including durable disease stabilization in a heavily pretreated patient population, in addition to the previously reported favorable safety profile. Key findings include: ·      Stable disease observed in >30% of evaluable patients ·      Prolonged treatment duration includes one patient extending beyond 16 months. ·      35% of patients remain on therapy...

Continue reading

AVITA Medical Names Cary Vance as Chief Executive Officer

Board appoints Cary Vance as President and Chief Executive OfficerFollows successful interim tenure and thorough search process by the BoardJan Stern Reed elected as Chair of the AVITA Medical BoardVALENCIA, Calif., April 30, 2026 (GLOBE NEWSWIRE) — AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, today announced that its Board of Directors has appointed Cary Vance as President and Chief Executive Officer, effective immediately. The Board of Directors has also appointed Jan Stern Reed as its Chair, effective immediately. Mr. Vance, who has served as Interim CEO since October 2025, will continue to serve on the Board as an executive member. “Following a thorough search process conducted in coordination with a top-tier, international executive search firm, the Board unanimously...

Continue reading

Primech Holdings Awarded Two Multi-Year Industrial Cleaning Contracts in Singapore Totaling Approximately US$3.45 Million

SINGAPORE, April 30, 2026 (GLOBE NEWSWIRE) — Primech Holdings Limited (Nasdaq: PMEC) (“Primech” or the “Company”), a Singapore-based provider of integrated facility services, today announced that its wholly owned subsidiaries, Maint-Kleen Pte Ltd and Primech A & P Pte Ltd, have been awarded two separate three-year cleaning service contracts within Singapore’s industrial sector. The combined estimated contract value is approximately US$3.45 million (approximately S$4.66 million), to be recognized over the contract terms. Contract DetailsMaint-Kleen Pte Ltd has secured a three-year contract valued at approximately US$1.4 million to deliver ongoing cleaning services across industrial property sites, supporting recurring, high-frequency service requirements. Primech A & P Pte Ltd has secured a three-year contract valued...

Continue reading

Orbit International’s Q-Vio Subsidiary Receives Prototype Orders in Support of its Next Generation Handheld Unit Being Developed by Technology Advancement Group to Replace Defense Advanced GPS Receiver Used by U.S. and Foreign Military Services

HAUPPAUGE, N.Y., April 30, 2026 (GLOBE NEWSWIRE) — Orbit International Corp. (the “Company”) (OTCID Basic Market:ORBT), an electronics manufacturer and software solution provider, today announced that its subsidiary, Q-Vio Corp. (“Q-Vio”) has received additional prototype orders from its customer Technology Advancement Group (“TAG”). These prototype orders are in support of TAG’s continued testing of its handheld unit being developed by TAG that will be used to upgrade and replace the Defense Advanced GPS Receiver (“DAGR”) for the United States Department of War and select foreign military services. Q-Vio will provide an LCD assembly as well as other parts adding to the protection and durability of TAG’s handheld unit. In June 2023, TAG was selected as the prime contractor for the effort to replace the DAGR. TAG’s handheld unit...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.